Neuroendocrine tumors future or investigational therapies

	Neuroendocrine tumors Microchapters
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk factors
Natural History, Complications and Prognosis
History and Symptoms
Laboratory Findings
CT scan
PET scan
Medical Therapy
Surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Therapies based on growth factor inhibitors are in the experimental stage. These inhibitors of epidermal growth factor receptors (EGFRs), of vascular endothelial growth factor receptors (VEGFRs), and of angiopoietin-related growth factor (AGF) include imatinib, sunitinib, temozolide, thalidomide, sorafenib, and panitumumab.